Braftovi Drug Interactions: 76 Major, 1013 Moderate
Braftovi (Encorafenib) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Braftovi. Always confirm against the full prescribing information.
100 interactions
Abacavir
The metabolism of Abacavir can be decreased when combined with Encorafenib.
Level 2 evidence
Abatacept
The metabolism of Encorafenib can be increased when combined with Abatacept.
Level 1 evidence
Abiraterone
The metabolism of Encorafenib can be decreased when combined with Abiraterone.
Level 1 evidence
Abrocitinib
The serum concentration of Encorafenib can be increased when it is combined with Abrocitinib.
Level 2 evidence
Acamprosate
The risk or severity of liver damage can be increased when Acamprosate is combined with Encorafenib.
Level 2 evidence
Acarbose
The risk or severity of liver damage can be increased when Acarbose is combined with Encorafenib.
Level 2 evidence
Acebutolol
The risk or severity of QTc prolongation can be increased when Encorafenib is combined with Acebutolol.
Level 1 evidence
Aceclofenac
The risk or severity of liver damage can be increased when Aceclofenac is combined with Encorafenib.
Level 2 evidence
Acenocoumarol
The serum concentration of Acenocoumarol can be increased when it is combined with Encorafenib.
Level 1 evidence
Acetaminophen
The metabolism of Acetaminophen can be decreased when combined with Encorafenib.
Level 2 evidence
Acetazolamide
The risk or severity of liver damage can be increased when Acetazolamide is combined with Encorafenib.
Level 2 evidence
Acetohydroxamic acid
The risk or severity of liver damage can be increased when Acetohydroxamic acid is combined with Encorafenib.
Level 2 evidence
Enter your NPI to unlock 5 major interactions for Braftovi
Braftovi (Encorafenib) has 1207 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Braftovi (Encorafenib) has 76 major, 1013 moderate, and 118 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Braftovi. Always confirm against the full prescribing information.